Company: MTCH
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000891103-25-000027
Chunk: 148

Company: Match Group, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 7
Chunk 148
---
 Unallocated costs.

Product development expenseYears Ended December 31,2024$ Change% Change2023$ Change% Change2022(Dollars in thousands)Product development expense$442,175 $57,990 15%$384,185 $50,546 15%$333,639 Percentage of revenue13%11%10%

For the year ended December 31, 2024 compared to the year ended December 31, 2023

Product development expense increased primarily due to increases in employee compensation expense of $24.5 million and stock-based compensation expense of $26.3 million, both due to increased headcount at Hinge and Tinder, partially offset by a decrease at E&E.

41

For the year ended December 31, 2023 compared to the year ended December 31, 2022

Product development expense increased primarily due to increases in employee compensation expense of $18.3 million and stock-based compensation expense of $33.7 million, both due to increased headcount at both Hinge and Tinder.

DepreciationYears Ended December 31,2024$ Change% Change2023$ Change% Change2022(Dollars in thousands)Depreciation $87,499 $25,692 42%$61,807 $18,213 42%$43,594 Percentage of revenue3%2%1%

For the year ended December 31, 2024 compared to the year ended December 31, 2023

Depreciation was higher in 2024 as compared to 2023 primarily due to internally developed software at Tinder, MG Asia, and E&E.

For the year ended December 31, 2023 compared to the year ended December 31, 2022

Depreciation was higher in 2023 as compared to 2022 primarily due to an increase in internally developed software placed in service at Tinder and MG Asia.

Impairments and amortization of intangiblesYears Ended December 31,2024$ Change% Change2023$ Change% Change2022(Dollars in thousands)Impairments and amortization of intangibles$74,175 $26,444 55%$47,731 $(318,526)(87)%$366,257 Percentage of revenue2%1%11%

For the year ended December 31, 2024 compared to the year ended December 31, 2023

Impairments and